Aptamer Group (APTA) Share Price

Health Care Sector


NOTE: This is based on 17 open tips for Aptamer Group (APTA)


Aptamer Group (APTA)
Latest Quote Price

0.28p

Aptamer Group (APTA)
Price Change (%)

-6.06%


Latest Bid : 0.25p Latest Ask : 0.30p
High Today : 0.30p Low Today : 0.26p
This Years High : 1.32p This Years Low : 0.20p
Volume : 1,966,979 MKT Cap : £5.38M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Aptamer Group (APTA) Overview

Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.

Aptamer Group (APTA) Latest Tips

Type Tipster SectorScore Start date Performance
Sell Steve Moore Premium Only 2024-11-06 17:35:00 06/11/2024 -14.58%
Avoid Steve Moore Premium Only 2024-06-14 10:55:00 14/06/2024 60.71%
Avoid Steve Moore Premium Only 2024-05-23 13:20:00 23/05/2024 63.33%
Avoid Steve Moore Premium Only 2024-02-05 11:10:00 05/02/2024 63.33%
Avoid Steve Moore Premium Only 2023-12-14 14:30:00 14/12/2023 77.08%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Aptamer Group (APTA) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.25p Latest Ask : 0.30p
High Today : 0.30p Low Today : 0.26p
This Years High : 1.32p This Years Low : 0.20p
Volume : 1,966,979 MKT Cap : £5.38M

Aptamer Group Overview

Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Aptamer Group Tips

Type Tipster SectorScore Start date Performance
Sell Steve Moore Premium Only 2024-11-06 17:35:00 06/11/2024 -14.58%
Avoid Steve Moore Premium Only 2024-06-14 10:55:00 14/06/2024 60.71%
Avoid Steve Moore Premium Only 2024-05-23 13:20:00 23/05/2024 63.33%
Avoid Steve Moore Premium Only 2024-02-05 11:10:00 05/02/2024 63.33%
Avoid Steve Moore Premium Only 2023-12-14 14:30:00 14/12/2023 77.08%